Leukaemia UK announces Project Grant Programme

Awards are made for innovative research with the potential for high research impact.

They fund only innovative research of the highest scientific quality that promises to expand their understanding of leukaemia and other blood cancers, or to discover and develop new treatments for the disease, which ultimately aim to improve the outcomes for all those diagnosed.

Scope

• The proposed research project must have relevance to leukaemia UK, and/or other related diseases. The proposed research must demonstrate the potential for advancement in the fundamental understanding of leukaemia and/or related diseases or improvement in diagnosis and/or treatment. Translational projects are particularly encouraged.
• Leukaemia UK’s Project Grant awards will fund only novel, clearly defined projects and will not financially supplement existing research projects.
• Successful applications must be able to demonstrate:
  • An innovative research project idea
  • Scientific excellence
  • The potential for high scientific and/or clinical impact.

Funding Information

• Grants are for up to £250k, to span a maximum duration of three years.

Eligibility Criteria

• Relevant, high quality and feasible applications are invited from established clinician scientists and/or research scientists, who are group leaders or at group leader level, with an outstanding research track record.
• Joint applications can be submitted, by a Lead applicant and a Co-applicant, subject to the following criteria:
  • Lead applicant: The ‘Principal Investigator’ for the proposed research. This must be a senior clinician scientist/senior research scientist, a group leader, or at group leader level. The Lead applicant will have overall responsibility for the project and must be affiliated with a UK research centre, which will be deemed as the ‘Host Institution’ for contractual purposes.
  • Co-applicant: An investigator who will contribute to the research project but need not be affiliated with the ‘Host Institution’. The Co-applicant should be an established clinician scientist or research scientist but need not be a group leader or at group leader level.
  • Host Institution: A non-profit research centre of excellence within the UK that will provide the facilities for carrying out the proposed research project.

For more information, visit Leukaemia UK.